New to Meducation?
Sign up
Already signed up? Log In

Category

13
1
15

SABCS 2008 | Case12

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 56-year-old premenopausal woman with a 2.2-cm, ER/PR-positive, HER2-negative, node-negative IDC with 88 percent Ki-67. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
almost 9 years ago
10
1
10

SABCS Spin-Off | 06 - Buzdar

For postmenopausal women with ER-positive, metastatic disease, tamoxifen, an aromatase inhibitor or fulvestrant are essentially equivalent choices.  
Dr Neil Love
almost 9 years ago
11
1
14

SABCS Spin-Off | 06 - Hudis

Outside a protocol setting, dose-dense AC ->paclitaxel, administered every two weeks with growth factors, with trastuzumab during and following the paclitaxel, provides the best potential risk/benefit profile for women with HER2-positive, node-positive disease.  
Dr Neil Love
almost 9 years ago
12
1
21

SABCS Spin-Off | 06 - Dixon

Neoadjuvant therapy with an aromatase inhibitor provides the best potential risk/benefit profile for postmenopausal women with HER2-negative, strongly ER-positive and PR-positive disease.  
Dr Neil Love
almost 9 years ago
0
1
25

SABCS Spin-Off | 06 - Mackey

Outside a protocol setting, a combination of endocrine therapy and trastuzumab provides the best potential risk/benefit profile for women with ER-positive, HER2-positive metastatic disease.  
Dr Neil Love
almost 9 years ago
1
1
24

SABCS Spin-Off | 06 - Tripathy

Outside a protocol setting, the combination of lapatinib and capecitabine provides the best potential risk/benefit profile for women with ER-negative, PR-negative, HER2-positive, node-positive disease with cancer recurrence after AC->TH.  
Dr Neil Love
almost 9 years ago
0
1
16

HOUJC1 2009 | Case 1

ResearchToPractice.com/HOUJC109 – Case 1: 73yo woman with recurrent, fludarabine-refractory chronic lymphocytic leukemia with lymphadenopathy, splenomegaly and anemia. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
almost 9 years ago
2
1
18

HOUJC1 2009 | Case 3

ResearchToPractice.com/HOUJC109 – Case 3: 75yo woman initially treated with R-CHOP for Stage IV diffuse large B-cell lymphoma and then with R-EPOCH for recurrent disease. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
almost 9 years ago
4
2
24

HOUJC1 2009 | Case 5

ResearchToPractice.com/HOUJC109 – Case 5: 53yo woman with symptomatic, high-risk mantle-cell lymphoma treated with R-hyper-CVAD. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
almost 9 years ago
6
1
15

HOUJC1 2009 | Case 7

ResearchToPractice.com/HOUJC109 – Case 7: A 40-year-old woman with symptomatic, nonbulky peripheral T-cell lymphoma and extensive adenopathy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
almost 9 years ago
6
1
19

MTPH1 2009 | Case 3 presented by Isaac Levy, MD

ResearchToPractice.com/MTPH109 – Case 3 from the practice of Isaac Levy, MD presented to Drs Gregory and Orlowski, moderated by Neil Love, MD. An 83-year-old woman with mantle-cell lymphoma experienced a complete response to R-CHOP. Produced by Research To Practice.  
Dr Neil Love
almost 9 years ago
11
1
11

MTPH1 2009 | Case 8 presented by Lowell L Hart, MD

<p>ResearchToPractice.com/MTPH109 – Case 8 from the practice of Lowell L Hart, MD presented to Drs Gregory and Orlowski, moderated by Neil Love, MD. A 70-year-old woman with MM experienced a near-complet <br />remission with reduced-dose lenalidomide/dexamethasone followed by pamidronate maintenance therapy. Produced by Research To Practice.</p>  
Dr Neil Love
almost 9 years ago
13
1
13

MTPB4 2007 | Case 04 Patterns of Care Discussion

MeetTheProfessors.com – Patterns of Care Case Discussion; postmenopausal woman with progressive Stage IV, ER-positive, HER2-negative breast cancer presented to Drs Winer and Carey  
Dr Neil Love
almost 9 years ago
2
1
13

MTPB4 2007 | Case 07 presented by Patricia J Madej, MD

MeetTheProfessors.com – Case from the practice of Patricia J Madej, MD; premenopausal 48-year-old woman; mastectomy for two ipsilateral, discrete, ER-pos, PR-pos, HER2-neg breast lesions presented to Drs Winer and Carey  
Dr Neil Love
almost 9 years ago
9
1
7

MTPB3 2007 | Case 01 presented by Bonni L Gearhart, MD

www.MeetTheProfessors.com – Case from the practice of Bonni L Gearhart, MD; 49-year-old obese woman presented to Drs Cobleigh, Holmes  
Dr Neil Love
almost 9 years ago
10
1
13

MTPB3 2007 | Case 02 presented by Carolyn B Hendricks, MD

www.MeetTheProfessors.com – Case from the practice of Carolyn B Hendricks, MD; 44-year-old woman diagnosed two years prior with a 2.2-cm, Grade III, triple-negative IDC with negative axillary node dissection presented to Drs Cobleigh, Holmes  
Dr Neil Love
almost 9 years ago
11
1
16

MTPB3 2007 | Case 03 presented by Richard S Zelkowitz, MD

www.MeetTheProfessors.com – Case from the practice of Richard S Zelkowitz, MD; 51yo perimenopausal woman diagnosed in ’02 with two distinct, ipsilateral breast lesions in different quadrants, measuring 0.8cm and 2.5cm presented to Drs Cobleigh, Holmes  
Dr Neil Love
almost 9 years ago
13
1
15

MTPB3 2007 | Case 05 presented by Lowell L Hart, MD

www.MeetTheProfessors.com – Case from the practice of Lowell L Hart, MD; 59-year-old woman in excellent health diagnosed with a 3.1-cm, highly proliferative, triple-negative, node-negative breast tumor presented to Drs Cobleigh, Holmes  
Dr Neil Love
almost 9 years ago
1
1
24

MTPB3 2007 | Case 07 presented by Kenneth R Hoffman, MD

www.MeetTheProfessors.com – Case from the practice of Kenneth R Hoffman, MD; 34-year-old woman in her tenth week of pregnancy was found to have a 2.3-cm, ER-negative, PR-negative, HER2-positive IDC presented to Drs Cobleigh, Holmes  
Dr Neil Love
almost 9 years ago
4
1
3

MTPB3 2007 | Case 10 presented by Alan B Astrow, MD

www.MeetTheProfessors.com – Case from the practice of Alan B Astrow, MD; 86-year-old woman was found to have a 1.9-cm, Grade II, ER-negative, PR-negative, HER2-positive IDC with six of 15 positive axillary nodes presented to Drs Schwartzberg, Seidman  
Dr Neil Love
almost 9 years ago